Evidence map›Paper›PMID 32512889›Full record

ArticleInternational journal of molecular sciences2020

Repeated Freezing Procedures Preserve Structural and Functional Properties of Amniotic Membrane for Application in Ophthalmology.

Olena Pogozhykh, Nicola Hofmann, Oleksandr Gryshkov, Constantin von Kaisenberg, Marc Mueller, Birgit Glasmacher, Denys Pogozhykh, Martin Börgel, Rainer Blasczyk, Constança Figueiredo

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.0field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Olena PogozhykhInstitute of Transfusion Medicine and Transplant Engineering, Hannover Medical School, 30625 Hannover, Germany.ORCID 0000-0003-1086-5190
Nicola HofmannGerman Society for Tissue Transplantation (DGFG), 30625 Hannover, Germany.
Oleksandr GryshkovInstitute for Multiphase Processes, Gottfried Wilhelm Leibniz Universität Hannover, 30167 Hannover, Germany.
Constantin von KaisenbergDepartment of Obstetrics and Gynecology, Hannover Medical School, 30625 Hannover, Germany.
Marc MuellerInstitute for Multiphase Processes, Gottfried Wilhelm Leibniz Universität Hannover, 30167 Hannover, Germany.
Birgit GlasmacherInstitute for Multiphase Processes, Gottfried Wilhelm Leibniz Universität Hannover, 30167 Hannover, Germany.ORCID 0000-0002-2452-1666
Denys PogozhykhInstitute of Transfusion Medicine and Transplant Engineering, Hannover Medical School, 30625 Hannover, Germany.
Martin BörgelGerman Society for Tissue Transplantation (DGFG), 30625 Hannover, Germany.
Rainer BlasczykInstitute of Transfusion Medicine and Transplant Engineering, Hannover Medical School, 30625 Hannover, Germany.
Constança FigueiredoInstitute of Transfusion Medicine and Transplant Engineering, Hannover Medical School, 30625 Hannover, Germany.ORCID 0000-0003-2786-0388
Medizinische Hochschule Hannover · DELeibniz University Hannover · DEGerman Society of Surgery · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For decades, the unique regenerative properties of the human amniotic membrane (hAM) have been successfully utilized in ophthalmology. As a directly applied biomaterial, the hAM should be available in a ready to use manner in clinical settings. However, an extended period of time is obligatory for performing quality and safety tests. Hence, the low temperature storage of the hAM is a virtually inevitable step in the chain from donor retrieval to patient application. At the same time, the impact of subzero temperatures carries an increased risk of irreversible alterations of the structure and composition of biological objects. In the present study, we performed a comprehensive analysis of the hAM as a medicinal product; this is intended for a novel strategy of application in ophthalmology requiring a GMP production protocol including double freezing-thawing cycles. We compared clinically relevant parameters, such as levels of growth factors and extracellular matrix proteins content, morphology, ultrastructure and mechanical properties, before and after one and two freezing cycles. It was found that epidermal growth factor (EGF), transforming growth factor beta 1 (TGF-β1), hepatocyte growth factor (HGF), basic fibroblast growth factor (bFGF), hyaluronic acid, and laminin could be detected in all studied conditions without significant differences. Additionally, histological and ultrastructure analysis, as well as transparency and mechanical tests, demonstrated that properties of the hAM required to support therapeutic efficacy in ophthalmology are not impaired by dual freezing.

Indexed as

FreezingOphthalmologyAmnionCryoelectron MicroscopyCryopreservationHumansMechanical PhenomenaAmnioClip-plusamniotic membranecryomicroscopycryopreservationgrowth factorsocular surface disorderultrastructure

Identifiers

PMID32512889
PMCPMC7312941
OpenAlexW3034102119

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.